These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26548536)

  • 1. [Necrotic leg ulcer revealing vasculitis induced by vitamin K antagonists].
    Chabli H; Hocar O; Akhdari N; Amal S; Hakkou M; Hamdaoui A
    J Mal Vasc; 2015 Dec; 40(6):402-5. PubMed ID: 26548536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Necrotic leg ulcers induced by vitamin K antagonists: five cases].
    Bezier M; Perceau G; Reguiai Z; Remy-Leroux V; Tchen T; Durlach A; Grange F; Nguyen P; Bernard P
    Ann Dermatol Venereol; 2011 Oct; 138(10):657-63. PubMed ID: 21978501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recurrent pyoderma gangrenosum-like ulcers induced by oral anticoagulants].
    Pralong P; Debarbieux S; Paret N; Balme B; Depaepe L; Nosbaum A; Ben-Said B; Nicolas JF; Bérard F
    Ann Dermatol Venereol; 2014 Jan; 141(1):34-8. PubMed ID: 24461092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vitamin K antagonist-induced necrotic leg ulcer, without protein C and S deficiencies].
    Kurihara F; Tella E; Sigal ML; Mahé E
    Rev Med Interne; 2018 Jan; 39(1):50-53. PubMed ID: 28867534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acenocoumarol and vasculitis: a case report.
    Aouam K; Gassab A; Khorchani H; Bel Hadj Ali H; Amri M; Boughattas NA; Zili JE
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):113-4. PubMed ID: 16981216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retrospective study of hypertensive leg ulcers at Reims University Hospital: Epidemiological, clinical, disease progression data, effects of vitamin K antagonists].
    Nicol P; Bernard P; Nguyen P; Durlach A; Perceau G
    Ann Dermatol Venereol; 2017 Jan; 144(1):37-44. PubMed ID: 27771120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acenocoumarol and vasculitis - a rare case].
    Abreu P; Duarte C; Malcata A
    Acta Reumatol Port; 2010; 35(3):366-9. PubMed ID: 20975642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calciphylaxis associated with cholangiocarcinoma treated with low-molecular-weight heparin and vitamin K.
    Riegert-Johnson DL; Kaur JS; Pfeifer EA
    Mayo Clin Proc; 2001 Jul; 76(7):749-52. PubMed ID: 11444409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Necrotic leg ulcers after topical application of chlormethine].
    Gary C; Gautier V; Lazareth I; Bagot M; Asgari R; Priollet P
    Ann Dermatol Venereol; 2019 Mar; 146(3):226-231. PubMed ID: 30704945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.
    Roldán V; Cancio S; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Am J Med; 2015 Nov; 128(11):1237-43. PubMed ID: 26087049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrupt versus gradual withdrawal of vitamin K antagonist treatment in patients with venous thromboembolic disease: assessment of hypercoagulability and clinical outcome.
    de Groot MR; Njo TL; van Marwijk Kooy M; Büller HR
    Clin Lab; 2000; 46(11-12):575-81. PubMed ID: 11109505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors associated with a thrombotic or bleeding event in patients treated with vitamin K antagonists.
    Béné J; Dubart AE; Senis C; Auffret M; Caron J; Gautier S
    J Mal Vasc; 2014 Jul; 39(4):248-55. PubMed ID: 24889788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected Problems of Antithrombotic Therapy with An Unusual Side Effect of Vitamin K Antagonists after Mitral Valve Replacement.
    Marchandot B; Messas N; Jesel L; Trinh A; Kibler M; Reydel A; Ohlmann P; Morel O
    J Heart Valve Dis; 2017 May; 26(3):309-313. PubMed ID: 29092116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral anticoagulation with vitamin K antagonists].
    Alberio L
    Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical calciphylaxis secondary to treatment with acenocoumarol.
    Alvarez-Pérez A; Gutiérrez-González E; Sánchez-Aguilar D; Toribio J
    Actas Dermosifiliogr; 2012 Jan; 103(1):79-81. PubMed ID: 22444506
    [No Abstract]   [Full Text] [Related]  

  • 17. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.
    Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A
    Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein: a clue to vitamin K antagonist stabilization.
    Gschwind L; Rollason V; Boehlen F; Rebsamen M; Combescure C; Matthey A; Bonnabry P; Dayer P; Desmeules JA
    Pharmacogenomics; 2015 Jan; 16(2):129-36. PubMed ID: 25616099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemocholecyst: rare complication of oral anticoagulation].
    Van Gossum A; Meunier M; Boisdenghien A
    Gastroenterol Clin Biol; 1983 Jan; 7(1):98. PubMed ID: 6840453
    [No Abstract]   [Full Text] [Related]  

  • 20. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.